262 related articles for article (PubMed ID: 20660620)
1. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury.
Kishk NA; Gabr H; Hamdy S; Afifi L; Abokresha N; Mahmoud H; Wafaie A; Bilal D
Neurorehabil Neural Repair; 2010 Oct; 24(8):702-8. PubMed ID: 20660620
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for publishing case studies of cell transplantation for spinal cord injury.
Dobkin BH
Neurorehabil Neural Repair; 2010 Oct; 24(8):687-91. PubMed ID: 20921329
[TBL] [Abstract][Full Text] [Related]
3. Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome.
Osaka M; Honmou O; Murakami T; Nonaka T; Houkin K; Hamada H; Kocsis JD
Brain Res; 2010 Jul; 1343():226-35. PubMed ID: 20470759
[TBL] [Abstract][Full Text] [Related]
4. A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury.
Jung DI; Ha J; Kang BT; Kim JW; Quan FS; Lee JH; Woo EJ; Park HM
J Neurol Sci; 2009 Oct; 285(1-2):67-77. PubMed ID: 19555980
[TBL] [Abstract][Full Text] [Related]
5. Autologous mesenchymal stem cells in chronic spinal cord injury.
Bhanot Y; Rao S; Ghosh D; Balaraju S; Radhika CR; Satish Kumar KV
Br J Neurosurg; 2011 Aug; 25(4):516-22. PubMed ID: 21749185
[TBL] [Abstract][Full Text] [Related]
6. Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord.
Zhang W; Yan Q; Zeng YS; Zhang XB; Xiong Y; Wang JM; Chen SJ; Li Y; Bruce IC; Wu W
Brain Res; 2010 Nov; 1359():256-71. PubMed ID: 20816761
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans.
Park JH; Kim DY; Sung IY; Choi GH; Jeon MH; Kim KK; Jeon SR
Neurosurgery; 2012 May; 70(5):1238-47; discussion 1247. PubMed ID: 22127044
[TBL] [Abstract][Full Text] [Related]
8. Transplanted neurally modified bone marrow-derived mesenchymal stem cells promote tissue protection and locomotor recovery in spinal cord injured rats.
Alexanian AR; Fehlings MG; Zhang Z; Maiman DJ
Neurorehabil Neural Repair; 2011; 25(9):873-80. PubMed ID: 21844281
[TBL] [Abstract][Full Text] [Related]
9. Olfactory ensheathing cells for human spinal cord injury.
Lopes A
Neurorehabil Neural Repair; 2010 Oct; 24(8):772-3; author reply 772-3. PubMed ID: 20936775
[No Abstract] [Full Text] [Related]
10. Olfactory ensheathing cells for human spinal cord injury.
de Carvalho M
Neurorehabil Neural Repair; 2010 Oct; 24(8):772; author reply 772. PubMed ID: 20936774
[No Abstract] [Full Text] [Related]
11. Olfactory ensheathing cells for human spinal cord injury.
Wernig A; Wernig S
Neurorehabil Neural Repair; 2010 Oct; 24(8):770-2; author reply 770-2. PubMed ID: 20921330
[No Abstract] [Full Text] [Related]
12. Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury.
Dai G; Liu X; Zhang Z; Yang Z; Dai Y; Xu R
Brain Res; 2013 Oct; 1533():73-9. PubMed ID: 23948102
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study.
Yamout B; Hourani R; Salti H; Barada W; El-Hajj T; Al-Kutoubi A; Herlopian A; Baz EK; Mahfouz R; Khalil-Hamdan R; Kreidieh NM; El-Sabban M; Bazarbachi A
J Neuroimmunol; 2010 Oct; 227(1-2):185-9. PubMed ID: 20728948
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of human marrow stromal cells and mono-nuclear bone marrow cells into the injured spinal cord: a comparative study.
Samdani AF; Paul C; Betz RR; Fischer I; Neuhuber B
Spine (Phila Pa 1976); 2009 Nov; 34(24):2605-12. PubMed ID: 19881401
[TBL] [Abstract][Full Text] [Related]
15. Implanted spike wave electric stimulation promotes survival of the bone marrow mesenchymal stem cells and functional recovery in the spinal cord injured rats.
Wu W; Zhao H; Xie B; Liu H; Chen Y; Jiao G; Wang H
Neurosci Lett; 2011 Mar; 491(1):73-8. PubMed ID: 21232582
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data.
Kumar AA; Kumar SR; Narayanan R; Arul K; Baskaran M
Exp Clin Transplant; 2009 Dec; 7(4):241-8. PubMed ID: 20353375
[TBL] [Abstract][Full Text] [Related]
17. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells.
Hu SL; Luo HS; Li JT; Xia YZ; Li L; Zhang LJ; Meng H; Cui GY; Chen Z; Wu N; Lin JK; Zhu G; Feng H
Crit Care Med; 2010 Nov; 38(11):2181-9. PubMed ID: 20711072
[TBL] [Abstract][Full Text] [Related]
18. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury.
Abrams MB; Dominguez C; Pernold K; Reger R; Wiesenfeld-Hallin Z; Olson L; Prockop D
Restor Neurol Neurosci; 2009; 27(4):307-21. PubMed ID: 19738324
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of a combination of autologous neural differentiated and undifferentiated mesenchymal stem cells into injured spinal cord of rats.
Pedram MS; Dehghan MM; Soleimani M; Sharifi D; Marjanmehr SH; Nasiri Z
Spinal Cord; 2010 Jun; 48(6):457-63. PubMed ID: 20010910
[TBL] [Abstract][Full Text] [Related]
20. [Effect of transplanting marrow mesenchymal stem cells via subarachnoid space on spinal cord injury and T cell subpopulation in rats].
Wu J; Feng D; Yang T
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):492-6. PubMed ID: 17578289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
